MDGL 股东权益历史(2012–2025)
MADRIGAL PHARMACEUTICALS, INC. (MDGL) 各财年年末股东权益(来自 SEC 财报)。
$602.7MFY2025 · FY2012 以来:$75.1M → $602.7M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $602.7M | -20.1% |
| FY2024 | $754.4M | +86.1% |
| FY2023 | $405.3M | +105.3% |
| FY2022 | $197.4M | +0.7% |
| FY2021 | $196.1M | -18.3% |
| FY2020 | $240.0M | -42.4% |
| FY2019 | $416.6M | -12.7% |
| FY2018 | $477.0M | +161.7% |
| FY2017 | $182.3M | — |
| FY2012 | $75.1M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议